Serveur d'exploration H2N2 - Exploration (Accueil)

Index « Titre (en) » - entrée « inhibitor »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
inhibition < inhibitor < inhibitors  Facettes :

List of bibliographic references indexed by inhibitor

Number of relevant bibliographic references: 21.
[0-20] [0 - 20][0 - 21][20-20][20-40]
Ident.Authors (with country if any)Title
000411 (2016) Yan Wu [République populaire de Chine] ; Feng Gao [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Yuhai Bi [République populaire de Chine] ; Lifeng Fu [République populaire de Chine] ; Sankar Mohan [Canada] ; Yuhang Chen [République populaire de Chine] ; Xuebing Li [République populaire de Chine] ; B. Mario Pinto [Canada] ; Christopher J. Vavricka [République populaire de Chine] ; Po Tien [République populaire de Chine] ; George F. Gao [République populaire de Chine]Resistance to Mutant Group 2 Influenza Virus Neuraminidases of an Oseltamivir-Zanamivir Hybrid Inhibitor
000588 (2015) Ying Wu [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Yan Wu [République populaire de Chine] ; Qing Li [République populaire de Chine] ; Santosh Rudrawar ; Robin J. Thomson ; Mark Von Itzstein ; George F. Gao [République populaire de Chine] ; Jianxun Qi [République populaire de Chine]Atypical group 1 neuraminidase pH1N1-N1 bound to a group 1 inhibitor
000880 (2013) Yan Wu [République populaire de Chine] ; Guangrong Qin [République populaire de Chine] ; Feng Gao [République populaire de Chine] ; Yue Liu [République populaire de Chine] ; Christopher J. Vavricka [République populaire de Chine] ; Jianxun Qi [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; Kunqian Yu [République populaire de Chine] ; George F. Gao [République populaire de Chine]Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding
000A70 (2012) Lalitha Venkatramani [États-Unis] ; Eric S. Johnson [États-Unis] ; Gundurao Kolavi [États-Unis] ; Gillian M. Air [États-Unis] ; Wayne J. Brouillette [États-Unis] ; Blaine Hm Mooers [États-Unis]Crystal structure of a new benzoic acid inhibitor of influenza neuraminidase bound with a new tilt induced by overpacking subsite C6
000B09 (2012) Enguang Feng [République populaire de Chine] ; Deju Ye [République populaire de Chine] ; Jian Li [République populaire de Chine] ; Dengyou Zhang [République populaire de Chine] ; Jinfang Wang [République populaire de Chine] ; Fei Zhao [République populaire de Chine] ; Rolf Hilgenfeld [République populaire de Chine, Allemagne] ; Mingyue Zheng [République populaire de Chine] ; Hualiang Jiang [République populaire de Chine] ; Hong Liu [République populaire de Chine]Recent Advances in Neuraminidase Inhibitor Development as Anti‐influenza Drugs
000E55 (2010) Shuku Kubo [Japon] ; Takanori Tomozawa [Japon] ; Masayo Kakuta [Japon] ; Akane Tokumitsu [Japon] ; Makoto Yamashita [Japon]Laninamivir Prodrug CS-8958, a Long-Acting Neuraminidase Inhibitor, Shows Superior Anti-Influenza Virus Activity after a Single Administration▿
001274 (2008) Makoto Yamashita [Japon] ; Takanori Tomozawa [Japon] ; Masayo Kakuta [Japon] ; Akane Tokumitsu [Japon] ; Hatsumi Nasu [Japon] ; Shuku Kubo [Japon]CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity▿
001676 (2004) Hiroshi Kido [Japon] ; Yuushi Okumura [Japon] ; Hiroshi Yamada [Japon] ; Dai Mizuno [Japon] ; Youichirou Higashi [Japon] ; Mihiro Yano [Japon]Secretory leukoprotease inhibitor and pulmonary surfactant serve as principal defenses against influenza A virus infection in the airway and chemical agents up-regulating their levels may have therapeutic potential
001927 (2000) Irina A. Leneva [États-Unis] ; Noel Roberts [Royaume-Uni] ; Elena A. Govorkova [États-Unis] ; Olga G. Goloubeva [États-Unis] ; Robert G. Webster [États-Unis]The neuraminidase inhibitor GS4104 (oseltamivir phosphate) is efficacious against A/Hong Kong/156/97 (H5N1) and A/Hong Kong/1074/99 (H9N2) influenza viruses
001A08 (1999) Hiroshi Kido [Japon] ; Yoshihito Beppu [Japon] ; Yasuhiro Imamura [Japon] ; Ye Chen [Japon] ; Meiko Murakami [Japon] ; Kumiko Oba [Japon] ; Takae Towatari [Japon]The human mucus protease inhibitor and its mutants are novel defensive compounds against infection with influenza A and Sendai viruses
001A25 (1999) J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]Identification of a novel HA conformational change inhibitor of human influenza virus
001B20 (1998) S. Bantia [États-Unis] ; A. A. Ghate [États-Unis] ; S. L. Ananth [États-Unis] ; Y. Sudhakar Babu [États-Unis] ; G. M. Air [États-Unis] ; G. M. Walsh [États-Unis]Generation and characterization of a mutant of influenza A virus selected with the neuraminidase inhibitor BCX-140
001B79 (1997) In vitro activity of the neuraminidase inhibitor GS4071 against influenza viruses
001B83 (1997) GS 4104: A highly potent orally bioavailable influenza neuraminidase inhibitor
001B91 (1997) Characterization of influenza A viruses that are resistant to a fusion inhibitor related to podocarpic acid
001C78 (1996) Guangxiang Luo ; Richard Colonno ; Mark KrystalCharacterization of a Hemagglutinin-Specific Inhibitor of Influenza A Virus
001D50 (1995) Larisa V. Gubareva ; Charles R. Penn ; Robert G. WebsterInhibition of Replication of Avian Influenza Viruses by the Neuraminidase Inhibitor 4-Guanidino-2,4-dideoxy-2,3-dehydro- N -acetylneuraminic Acid
001E98 (1993) P. Bossart-Whitaker [Australie] ; M. Carson [Australie] ; Y. S. Babu [Australie] ; C. D. Smith [Australie] ; W. G. Laver [Australie] ; Gillian M. Air [Australie]Three-dimensional Structure of Influenza A N9 Neuraminidase and Its Complex with the Inhibitor 2-Deoxy 2,3-Dehydro- N -Acetyl Neuraminic Acid
001F74 (1992) Nobutaka Wakamiya [Japon] ; Yoshinobu Okuno [Japon] ; Fuyoko Sasao [Japon] ; Shigeharu Ueda [Japon] ; Kumiko Yoshimatsu [Japon] ; Masaharu Naiki [Japon] ; Takashi Kurimura [Japon]Isolation and characterization of conglutinin as an influenza A virus inhibitor
002551 (1984) P. K. Lim ; B. S. FaggManganese-catalyzed autoxidation of aqueous hydrazine: kinetics, mechanism, and catalyst―inhibitor conversion
002773 (1980) A. Yamada ; Y. Okuno ; M. Takahashi ; K. NakajimaProduction of an attenuated influenza A (H3N2) strain "KO-1" by recombination with A/Okuda/57 (H2N2) followed by selection of inhibitor-resistant virus.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "inhibitor" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "inhibitor" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    inhibitor
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021